In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. Khadija Khartit is a strategy, investment, and funding expert, and an ...
Jim Mueller, CFA, began his career as a scientist. He has five years of experience as a senior analyst and another four years as a research analyst. David Kindness is a Certified Public Accountant ...
About Main Street Capital Corp. Main Street Capital Corp is a business development company. It focuses on providing customized long-term debt and equity capital solutions to lower middle market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results